Form 4: Pfizer Executive Rady A. Johnson Reports Acquisition of Phantom Stock Units

Executive Vice President Rady A. Johnson reports acquiring phantom stock units in Pfizer through the Supplemental Savings Plan.

Summary

• Rady A. Johnson, an Executive Vice President at Pfizer Inc., filed a Form 4 on November 1, 2024, reporting a transaction that occurred on October 31, 2024.
• The transaction involved the acquisition of 7 phantom stock units through the Pfizer Supplemental Savings Plan (SSP).
• Each unit represents one phantom share of common stock.
• The price of the phantom stock units was $28.3.
• Following the reported transaction, Johnson directly owns 9,197 phantom stock units.
• These units are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. It doesn't inherently convey positive or negative sentiment.

Positives

• The acquisition of phantom stock units aligns the executive's interests with the company's performance.
• The Supplemental Savings Plan provides a mechanism for executives to accumulate wealth tied to the company's stock.

Industry Context

Form 4 filings are a routine part of executive compensation and provide transparency into the holdings of company insiders. Phantom stock units are a common form of deferred compensation used by many large companies.

Key Dates